Abstract: This disclosure describes 5-vinyl-3-isoxazolyl substituted pyridines and 5-vinyl-2-isoxazolin-3-yl substituted pyridines which possess anti-inflammatory activity.
Type:
Grant
Filed:
April 4, 1975
Date of Patent:
May 11, 1976
Assignee:
American Cyanamid Company
Inventors:
Lantz Stephen Crawley, Sidney Robert Safir
Abstract: This disclosure describes a novel series of active antibacterial agents derived by reaction of antibiotic AV290 with certain classes of alkyl halides.
Abstract: This invention relates to ureidotetralin compounds and derivatives and selected enantiomers thereof. This invention also relates to methods for the preparation of said compounds which are useful as animal growth regulators and/or herbicidal agents.
Type:
Grant
Filed:
February 7, 1974
Date of Patent:
April 27, 1976
Assignee:
American Cyanamid Company
Inventors:
Larry Dean Spicer, Joseph Michael Pensack, Robert Daniel Wilbur, Gary Michael Demkovich, deceased
Abstract: This invention relates to a method for enhancing the growth rate of animals, particularly farm animals such as livestock, by administering to said animals compositions containing a growth-enhancing amount of a ureidotetralin compound or derivative thereof.
Type:
Grant
Filed:
February 7, 1974
Date of Patent:
April 27, 1976
Assignee:
American Cyanamid Company
Inventors:
Larry Dean Spicer, Joseph Michael Pensack, Robert Daniel Wilbur, Gary Michael Demkovich, deceased
Abstract: This disclosure describes a reversible complex of antibiotic AV290 with an alkali metal alkyl sulfate and a process for preparing same. The complex is useful as an animal feed supplement which significantly enhances the growth rate of animals and poultry.
Abstract: This disclosure describes certain 15-deoxy prostanoic acid derivatives having a hydroxy group further along in the beta-chain, useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.
Type:
Grant
Filed:
June 19, 1974
Date of Patent:
April 13, 1976
Assignee:
American Cyanamid Company
Inventors:
Middleton Brawner Floyd, Jr., William James McGahren, Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes compounds of the class of 15-substituted-9-keto(or 9-hydroxy)prostanoic acids and the esters and cationic salts thereof, useful as inhibitors of gastric acid secretion.
Type:
Grant
Filed:
May 9, 1974
Date of Patent:
January 13, 1976
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes novel 11-deoxy-13,14-dihydro-prostaglandin-9-ketals useful as bronchodilators and as gastric acid secretion inhibitors.
Type:
Grant
Filed:
June 3, 1974
Date of Patent:
January 13, 1976
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Middleton Brawner Floyd, Jr., Martin Joseph Weiss
Abstract: This disclosure describes compounds of the class of N-substituted p-(1H-tetrazol-1-yl)phenylthio- or dithio-carbamates useful as antimicrobial agents.
Type:
Grant
Filed:
June 3, 1974
Date of Patent:
January 13, 1976
Assignee:
American Cyanamid Company
Inventors:
William Vincent Curran, Andrew Stephen Tomcufcik, Adma Schneller Ross
Abstract: This disclosure describes 3-triphenylmethoxy-1-alkynes, 3-triphenylmethoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.
Type:
Grant
Filed:
April 27, 1973
Date of Patent:
January 13, 1976
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, Middleton Brawner Floyd, Jr., John Frank Poletto, Robert Eugene Schaub, Martin Joseph Weiss